Pharmacological characterization of sex differences in the effects of dopaminergic drugs on effort-based decision making in rats

Aberman JE, Salamone JD (1999) Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement. Neuroscience 92(2):545–552. https://doi.org/10.1016/s0306-4522(99)00004-4

Article  CAS  PubMed  Google Scholar 

Albert PR (2015) Why is depression more prevalent in women? J Psychiatry Neurosci 40:219–221. https://doi.org/10.1503/jpn.150205

Article  PubMed  PubMed Central  Google Scholar 

Bailey MR, Chun E, Schipani E, Balsam PD, Simpson EH (2020) Dissociating the effects of dopamine D2 receptors on effort-based versus value-based decision making using a novel behavioral approach. Behav Neurosci 134(2):101–118. https://doi.org/10.1037/bne0000361

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bryce CA, Floresco SB (2016) Perturbations in effort-related decision-making driven by acute stress and corticotropin-releasing factor. Neuropsychopharmacology 41(8):2147–2159. https://doi.org/10.1038/npp.2016.15

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carratala-Ros C, López-Cruz L, SanMiguel N, Ibáñez-Marín P, Martínez-Verdú A, Salamone JD, Correa M (2020) Preference for Exercise vs. more sedentary reinforcers: validation of an animal model of Tetrabenazine-Induced Anergia. Front Behav Neurosci 13:289. https://doi.org/10.3389/fnbeh.2019.00289

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carratala-Ros C, Martínez-Verdú A, Olivares-García R, Salamone JD, Correa M (2023) Effects of the dopamine depleting agent tetrabenazine in tests evaluating different components of depressive-like behavior in mice: sex-dependent response to antidepressant drugs with SERT and DAT blocker profiles. Psychopharmacology 240(8):1615–1628. https://doi.org/10.1007/s00213-023-06412-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen JJ, Ondo WG, Dashtipour K, Swope DM (2012) Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther 34(7):1487–1504. https://doi.org/10.1016/j.clinthera.2012.06.010

Article  CAS  PubMed  Google Scholar 

Chong TT, Bonnelle V, Manohar S, Veromann KR, Muhammed K, Tofaris GK, Hu M, Husain M (2015) Dopamine enhances willingness to exert effort for reward in Parkinson’s disease. Cortex 69:40–46. https://doi.org/10.1016/j.cortex.2015.04.003

Article  PubMed  PubMed Central  Google Scholar 

Correa M, Pardo M, Bayarri P, López-Cruz L, San Miguel N, Valverde O, Ledent C, Salamone JD (2016) Choosing voluntary exercise over sucrose consumption depends upon dopamine transmission: effects of haloperidol in wild type and adenosine A2AKO mice. Psychopharmacology 233(3):393–404. https://doi.org/10.1007/s00213-015-4127-3

Article  CAS  PubMed  Google Scholar 

Cousins MS, Sokolowski JD, Salamone JD (1993) Different effects of nucleus accumbens and ventrolateral striatal dopamine depletions on instrumental response selection in the rat. Pharmacol Biochem Behav 46(4):943–951. https://doi.org/10.1016/0091-3057(93)90226-j

Article  CAS  PubMed  Google Scholar 

Cousins MS, Atherton A, Turner L, Salamone JD (1996) Nucleus accumbens dopamine depletions alter relative response allocation in a T-maze cost/benefit task. Behav Brain Res 74(1–2):189–197

Article  CAS  PubMed  Google Scholar 

Culbreth AJ, Moran EK, Barch DM (2018) Effort-based decision-making in schizophrenia. Curr Opin Behav Sci 22:1–6. https://doi.org/10.1016/j.cobeha.2017.12.003

Article  PubMed  Google Scholar 

Culbreth AJ, Moran EK, Kandala S, Westbrook A, Barch DM (2020) Effort, avolition and motivational experience in schizophrenia: analysis of behavioral and neuroimaging data with relationships to daily motivational experience. Clin Psychol Sci 8(3):555–568. https://doi.org/10.1177/2167702620901558

Article  PubMed  PubMed Central  Google Scholar 

Dluzen DE, McDermott JL (2008) Sex differences in dopamine-and vesicular monoamine‐transporter functions: implications for methamphetamine use and neurotoxicity. Ann N Y Acad Sci 1139(1):140–150

Article  CAS  PubMed  Google Scholar 

Ecevitoglu A, Edelstein GA, Presby RE, Rotolo RA, Yang JH, Quiles T, Okifo K, Conrad RT, Kovach A, Correa M, Salamone JD (2023) Effects of the atypical antipsychotic and D3/D2 dopamine partial agonist cariprazine on effort-based choice behavior: implications for modeling avolition. Psychopharmacology 240(8):1747–1757. https://doi.org/10.1007/s00213-023-06405-8

Article  CAS  PubMed  Google Scholar 

Ecevitoglu A, Meka N, Rotolo RA, Edelstein GA, Srinath S, Beard KR, Carratala-Ros C, Presby RE, Cao J, Okorom A, Newman AH, Correa M, Salamone JD (2024) Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors. Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-01826-1Advance online publication

Article  PubMed  Google Scholar 

Errante EL, Chakkalamuri M, Akinbo OI, Yohn SE, Salamone JD, Matuszewich L (2021) Sex differences in effort-related decision-making: role of dopamine D2 receptor antagonism. Psychopharmacology 238(6):1609–1619. https://doi.org/10.1007/s00213-021-05795-x

Article  CAS  PubMed  Google Scholar 

Floresco SB, Tse MT, Ghods-Sharifi S (2008) Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology 33(8):1966–1979. https://doi.org/10.1038/sj.npp.1301565

Article  CAS  PubMed  Google Scholar 

Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ (2013) Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiat 2013 74(2):130–136. https://doi.org/10.1016/j.biopsych.2012.12.022

Guay DRP (2010) Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Am J Geriat Pharmacother 8(4):331–373. https://doi.org/10.1016/j.amjopharm.2010.08.006

Article  CAS  Google Scholar 

Gullion CM, Rush AJ (1998) Toward a generalizable model of symptoms in major depressive disorder. Biol Psychiatry 44:959–972. https://doi.org/10.1016/s0006-3223(98)00235-2

Article  CAS  PubMed  Google Scholar 

Gürağaç Dereli FT, Ilhan M, Küpeli Akkol E (2020) Identification of the main active antidepressant constituents in a traditional Turkish medicinal plant, Centaurea Kurdica Reichardt. J Ethnopharmacol 249:112373. https://doi.org/10.1016/j.jep.2019.112373

Article  CAS  PubMed  Google Scholar 

Hart EE, Izquierdo A (2019) Quantity versus quality: Convergent findings in effort-based choice tasks. Behav Processes 164: 178–185 https://doi.org/10.1016/j.beproc.2019.05.009

Hosking JG, Floresco SB, Winstanley CA (2015) Dopamine antagonism decreases willingness to expend physical, but not cognitive, effort: a comparison of two rodent cost/benefit decision-making tasks. Neuropsychopharmacology 40(4):1005–1015. https://doi.org/10.1038/npp.2014.285

Article  CAS  PubMed  Google Scholar 

Jastrzębska-Więsek M, Wesołowska A, Kołaczkowski M, Varney MA, Newman-Tancredi A, Depoortere R (2022) The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat. Behav Pharmacol 33(5):333–341. https://doi.org/10.1097/FBP.0000000000000681

Article  CAS  PubMed  Google Scholar 

Katoh A, Eigyo M, Ishibashi C, Naitoh Y, Takeuchi M, Ibii N, Ikeda M, Matsushita A (1995) Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats. J Pharmacol Exp Ther 272(3):1067–1075

CAS  PubMed  Google Scholar 

Khan A, Brodhead AE, Schwartz KA, Kolts RL, Brown WA (2005) Sex differences in antidepressant response in recent antidepressant clinical trials. J Clin Psychopharmacol 25(4):318–324. https://doi.org/10.1097/01.jcp.0000168879.03169.ce

Article  PubMed  Google Scholar 

Kouhnavardi S, Ecevitoglu A, Dragačević V, Sanna F, Arias-Sandoval E, Kalaba P, Kirchhofer M, Lubec J, Niello M, Holy M, Zehl M, Pillwein M, Wackerlig J, Murau R, Mohrmann A, Beard KR, Sitte HH, Urban E, Sagheddu C, Pistis M, Plasenzotti R, Salamone JD, Langer T, Lubec G, Monje FJ (2022) A novel and selective dopamine transporter inhibitor, (S)-MK-26, promotes hippocampal synaptic plasticity and restores effort-related motivational dysfunctions. Biomolecules 12(7):881. https://doi.org/10.3390/biom12070881

Article  CAS  PubMed  PubMed Central  Google Scholar 

López-Cruz L, San Mig

Comments (0)

No login
gif